Humana (HUM) fundamentals: P/E, valuation, undervalued?
Humana · Health Care · ref. ETF XLV · price $420.38
In short — Humana trades at 39.7× earnings (P/E), 25.3× forward, with a net margin of 0.9 % and revenue growth of +26 %. Read: Cheap for the growth (P/E 25 for ~27% growth (PEG 0.9)).
Is Humana stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$420.38+60.7% over range
Oct 14, 25low $163.67 · high $433.5Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
56% recommend buying · 18 analysts
Valuation : Cheap for the growth — P/E 25 for ~27% growth (PEG 0.9)
Valuation
39.7
P/E (price/earnings)
25.3
Forward P/E
1.47
PEG
2.6
Price/book (P/B)
$50.5B
Market cap
10.58
EPS
Profitability & growth
0.9 %
Net margin
+26 %
Revenue growth
+27 %
Earnings growth
$14.7B
Total debt
Humana income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $92.9B | $2.8B | 3.0 % |
| 2023 | $106.4B | $2.5B | 2.3 % |
| 2024 | $117.8B | $1.2B | 1.0 % |
| 2025 | $129.7B | $1.2B | 0.9 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Humana's P/E and is the stock undervalued? What's a good P/E?
Humana's P/E is 39.7 (forward 25.3). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Humana profitable?
Humana has a net margin of 0.9 % (EPS 10.58). The company is profitable.
Is HUM stock expensive?
Our read: "Cheap for the growth" — P/E 25 for ~27% growth (PEG 0.9). Cross-check with growth and sector.
💬 A question about Humana? The JPI assistant answers using our backtest data.